GFAP and Alzheimer disease: Post hoc analyses revealed an interaction between plasma GFAP and WMH in promoting Alzheimer’s disease pathophysiology and downstream neurodegeneration, suggesting synergy between vascular and inflammatory processes in this proposed pathophysiological cascade.